← FDA Drug Approvals (Drugs@FDA)

IBANDRONATE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2015-10-16

Drug application

FDA Application #

ANDA204222

Application type

Abbreviated New Drug Application (Generic)

Brand name

IBANDRONATE SODIUM

Generic name

IBANDRONATE SODIUM

Active ingredients

IBANDRONATE SODIUM

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

APOTEX

Manufacturer

Apotex Corp.

First approval

2015-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown